Axsome Therapeutics's market cap is currently $5.79B. The company's EPS TTM is $-0.97; its P/E ratio is ―; Axsome Therapeutics is scheduled to report earnings on August 4, 2025, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
